In vivo confocal microscopy analysis successful in detecting OSSN characteristics

Article

Using in vivo microscopy analysis is a safe and effective diagnostic tool in detecting ocular surface squamous neoplasia (OSSN) characteristics

Using in vivo microscopy analysis is a safe and effective diagnostic tool in detecting ocular surface squamous neoplasia (OSSN) characteristics, claims a study in the journal Eye.

Dr Y Xu et al., Department of Ophthalmology, Peking University Eye Center, Peking University Third Hospital, Beijing, China, conducted a case series on five patients with OSSN. All characteristics were identified by in vivo confocal microscopy before surgery.

Structure and cellular features of OSSN were analysed with anterior-segment optical coherence tomography (AS-OCT) and confirmed by histopathological biopsy.

The anterior segment photography revealed tumours with red gelatinous surfaces with vascular dilation of the ocular surface and corneal epithelium. In three cases the AS-OCT found only tumours in the corneal epithelium, but the Bowman's layer and anterior stroma were invaded in two of the cases.

In three patients in vivo confocal microscopy revealed cellular anisocystosis and enlarged nuclei with a high nuclear to cytoplasmic ratio. Characteristics identified by histopathological biopsy were similar to the results identified by in vivo confocal microscopy in all patients.

Overall, the procedure is a safe, relatively non-invasive and effective tool in identifying OSSN characteristics. It is a valuable tool for managing OSSN patients.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.